Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386525596> ?p ?o ?g. }
- W4386525596 endingPage "4447" @default.
- W4386525596 startingPage "4447" @default.
- W4386525596 abstract "The purpose of this study was to report the clinical and patient-reported outcomes of children and adolescents with intracranial meningioma treated with pencil beam scanning proton therapy (PBS-PT).Out of a total cohort of 207 intracranial meningioma patients treated with PBS-PT between 1999 and 2022, 10 (4.8%) were children or adolescents aged < 18 years. Median age was 13.9 years (range, 3.2-17.2). Six (60%) children were treated as primary treatment (postoperative PT, n = 4; exclusive PT, n = 2) and four (40%) at the time of tumor recurrence. Acute and late toxicities were registered according to Common Terminology Criteria of Adverse Events (CTCAE). Quality of life (QoL) before PBS-PT was assessed using PEDQOL questionnaires. Educational, functional, and social aspects after PT were assessed through our in-house developed follow-up surveys. Median follow-up time was 71.1 months (range, 2.5-249.7), and median time to last questionnaire available was 37.6 months (range, 5.75-112.6).Five (50%) children developed local failure (LF) at a median time of 32.4 months (range, 17.7-55.4) after PBS-PT and four (80%) were considered in-field. One patient died of T-cell lymphoma 127.1 months after PBS-PT. Estimated 5-year local control (LC) and overall survival (OS) rates were 19.4% and 100.0%, respectively. Except for one patient who developed a cataract requiring surgery, no grade ≥3 late toxicities were reported. Before PT, patients rated their QoL lower than their parents in most domains. During the first year after PT, one child required educational support, one needed to attend to a special school, one had social problems and another three children required assistance for daily basic activities (DBA). Three years after PT, only one child required assistance for DBA.The outcome of children with intracranial meningioma treated with PBS-PT is in line with other centers who have reported results of radiation therapy delivered to this particular patient group. This therapy provides acceptable functional status profiles with no high-grade adverse radiation-induced events." @default.
- W4386525596 created "2023-09-08" @default.
- W4386525596 creator A5010230183 @default.
- W4386525596 creator A5017269693 @default.
- W4386525596 creator A5022660425 @default.
- W4386525596 creator A5033714271 @default.
- W4386525596 creator A5057875617 @default.
- W4386525596 creator A5060976792 @default.
- W4386525596 creator A5061177986 @default.
- W4386525596 creator A5072377859 @default.
- W4386525596 creator A5079226216 @default.
- W4386525596 creator A5080102649 @default.
- W4386525596 date "2023-09-06" @default.
- W4386525596 modified "2023-10-17" @default.
- W4386525596 title "Quality of Life, Clinical, and Patient-Reported Outcomes after Pencil Beam Scanning Proton Therapy Delivered for Intracranial Grade WHO 1–2 Meningioma in Children and Adolescents" @default.
- W4386525596 cites W1557215869 @default.
- W4386525596 cites W1597590045 @default.
- W4386525596 cites W1752066105 @default.
- W4386525596 cites W1966597732 @default.
- W4386525596 cites W1969964143 @default.
- W4386525596 cites W1971520354 @default.
- W4386525596 cites W1972136103 @default.
- W4386525596 cites W1973879463 @default.
- W4386525596 cites W1987002870 @default.
- W4386525596 cites W2007220200 @default.
- W4386525596 cites W2018024193 @default.
- W4386525596 cites W2019607817 @default.
- W4386525596 cites W2026642573 @default.
- W4386525596 cites W2034972449 @default.
- W4386525596 cites W2040145532 @default.
- W4386525596 cites W2043027713 @default.
- W4386525596 cites W2044218170 @default.
- W4386525596 cites W2047579575 @default.
- W4386525596 cites W2049350474 @default.
- W4386525596 cites W2050372748 @default.
- W4386525596 cites W2058859105 @default.
- W4386525596 cites W2061391099 @default.
- W4386525596 cites W2065384498 @default.
- W4386525596 cites W2076961554 @default.
- W4386525596 cites W2077506633 @default.
- W4386525596 cites W2082453808 @default.
- W4386525596 cites W2087790054 @default.
- W4386525596 cites W2091454617 @default.
- W4386525596 cites W2096915048 @default.
- W4386525596 cites W2102623447 @default.
- W4386525596 cites W2111783650 @default.
- W4386525596 cites W2113833237 @default.
- W4386525596 cites W2117837119 @default.
- W4386525596 cites W2124232983 @default.
- W4386525596 cites W2124960242 @default.
- W4386525596 cites W2128323985 @default.
- W4386525596 cites W2144094151 @default.
- W4386525596 cites W2148977460 @default.
- W4386525596 cites W2155799634 @default.
- W4386525596 cites W2289602271 @default.
- W4386525596 cites W2323149989 @default.
- W4386525596 cites W2514454733 @default.
- W4386525596 cites W2594478917 @default.
- W4386525596 cites W2607375230 @default.
- W4386525596 cites W2611412158 @default.
- W4386525596 cites W2612814978 @default.
- W4386525596 cites W2617219443 @default.
- W4386525596 cites W2628374912 @default.
- W4386525596 cites W2771810001 @default.
- W4386525596 cites W2791038000 @default.
- W4386525596 cites W2887682196 @default.
- W4386525596 cites W2908578072 @default.
- W4386525596 cites W2938284822 @default.
- W4386525596 cites W2939108807 @default.
- W4386525596 cites W2945990777 @default.
- W4386525596 cites W2982504092 @default.
- W4386525596 cites W3005990508 @default.
- W4386525596 cites W3009861980 @default.
- W4386525596 cites W3045687439 @default.
- W4386525596 cites W3081621683 @default.
- W4386525596 cites W3092975976 @default.
- W4386525596 cites W3095164687 @default.
- W4386525596 cites W3111027945 @default.
- W4386525596 cites W3112983658 @default.
- W4386525596 cites W3133726017 @default.
- W4386525596 cites W3182297551 @default.
- W4386525596 cites W3185055331 @default.
- W4386525596 cites W3198898208 @default.
- W4386525596 cites W3204812790 @default.
- W4386525596 cites W4211132876 @default.
- W4386525596 cites W4221025479 @default.
- W4386525596 cites W4223587362 @default.
- W4386525596 cites W4287831693 @default.
- W4386525596 cites W4292014127 @default.
- W4386525596 cites W4293529598 @default.
- W4386525596 doi "https://doi.org/10.3390/cancers15184447" @default.
- W4386525596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37760417" @default.
- W4386525596 hasPublicationYear "2023" @default.
- W4386525596 type Work @default.
- W4386525596 citedByCount "0" @default.
- W4386525596 crossrefType "journal-article" @default.
- W4386525596 hasAuthorship W4386525596A5010230183 @default.
- W4386525596 hasAuthorship W4386525596A5017269693 @default.